D. E. Shaw & Co, L.P.

13F Holdings History for Keros Therapeutics, Inc. - Common Stock, $0.0001 par value per share (KROS)

Symbol: KROS on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value per share
Latest Disclosed Ownership: 1.55M shares
Security Ownership: 5.1%

D. E. Shaw & Co., L.P. ownership in Keros Therapeutics, Inc. Common Stock, $0.0001 par value per share (KROS)

2025-10-27 - D. E. Shaw & Co., L.P. has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 1.55M shares of Keros Therapeutics, Inc. Common Stock, $0.0001 par value per share (KROS). This represents 5.1% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
D. E. Shaw & Co., L.P.	5.1%		$24.5M	1.55M			$15.82	13G	10/20/2025	27 Oct 2025 16:05:30